Risk factors for recurrent fever after the discontinuation of empiric antibiotic therapy for fever and neutropenia in pediatric patients with a malignancy or hematologic condition

This publication has 14 references indexed in Scilit:

• Hematologic predictors of bone marrow recovery in neutropenic patients hospitalized for fever: Implications for discontinuation of antibiotics and early discharge from the hospital
  The Journal of Pediatrics, 1992
• Febrile neutropenic events in cancer patients Treatment for fever and neutropenia in young adult patients during intensive chemotherapy for solid tumours
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1992
• Randomised comparison of oral ofloxacin alone with combination of parenteral antibiotics in neutropenic febrile patients
  The Lancet, 1992
• Single Daily Dose Ceftriaxone Plus Amikacin Treatment of Febrile Episodes in Neutropenic Patients Attending Day Hospital for Hematologic Malignancies
  Oncology, 1992
• Short Courses of Antibiotics in Selected Febrile Neutropenic Patients
  The Lancet Healthy Longevity, 1991
• The child with cancer and infection. I. Empiric therapy for fever and neutropenia, and preventive strategies
  The Journal of Pediatrics, 1991
• Early hospital discharge of children with cancer treated for fever and neutropenia: identification and management of the low-risk patient.
  Journal of Clinical Oncology, 1990
• Successful Intermittent Chemoprophylaxis forPneumocystis cariniiPneumonitis
  New England Journal of Medicine, 1987
• Duration of empiric antibiotic therapy in granulocytopenic patients with cancer
  The American Journal of Medicine, 1979
• Management of fever of unknown origin in patients with neoplasms and neutropenia
  Cancer, 1973